| pubmed-article:8564629 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8564629 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:8564629 | lifeskim:mentions | umls-concept:C0073992 | lld:lifeskim |
| pubmed-article:8564629 | lifeskim:mentions | umls-concept:C0079043 | lld:lifeskim |
| pubmed-article:8564629 | lifeskim:mentions | umls-concept:C0032861 | lld:lifeskim |
| pubmed-article:8564629 | lifeskim:mentions | umls-concept:C2926735 | lld:lifeskim |
| pubmed-article:8564629 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8564629 | pubmed:dateCreated | 1996-3-1 | lld:pubmed |
| pubmed-article:8564629 | pubmed:abstractText | The protective effect of a new long acting beta 2-agonist, salmeterol, against exercise-induced bronchoconstriction has been documented when given as inhaled aerosol. | lld:pubmed |
| pubmed-article:8564629 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8564629 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8564629 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8564629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8564629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8564629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8564629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8564629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8564629 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8564629 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8564629 | pubmed:issn | 1081-1206 | lld:pubmed |
| pubmed-article:8564629 | pubmed:author | pubmed-author:SchaanningJJ | lld:pubmed |
| pubmed-article:8564629 | pubmed:author | pubmed-author:VilsvikJJ | lld:pubmed |
| pubmed-article:8564629 | pubmed:author | pubmed-author:BrattenGG | lld:pubmed |
| pubmed-article:8564629 | pubmed:author | pubmed-author:HenriksenA... | lld:pubmed |
| pubmed-article:8564629 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8564629 | pubmed:volume | 76 | lld:pubmed |
| pubmed-article:8564629 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8564629 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8564629 | pubmed:pagination | 57-60 | lld:pubmed |
| pubmed-article:8564629 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:meshHeading | pubmed-meshheading:8564629-... | lld:pubmed |
| pubmed-article:8564629 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8564629 | pubmed:articleTitle | Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction. | lld:pubmed |
| pubmed-article:8564629 | pubmed:affiliation | Dept. of Pulmonary Diseases, Regional Hospital, University of Trondheim, Norway. | lld:pubmed |
| pubmed-article:8564629 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8564629 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8564629 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
